Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8505, Japan.
Biomaterials. 2010 Dec;31(34):8939-45. doi: 10.1016/j.biomaterials.2010.08.008. Epub 2010 Sep 17.
Neural transplantation therapy using neural stem cells has received as potential treatments for neurodegenerative diseases. Indeed, this therapy is thought to be effective for replacement of degenerating neurons in restricted anatomical region. However, because injected neural stem cells integrate randomly into the host neural network, another approach is needed to establish a neural pathway between selective areas of the brain or treat widespread degeneration across multiple brain regions. One of the promising approaches might be a therapy using pre-made neural network in vitro by the tissue engineering technique. In this study, we engineered a three-dimensional (3D) tissue with a neuronal network that can be easily manipulated and transplanted onto the host brain tissue in vivo. A polydimethylsiloxane microchamber array facilitated the formation of multiple neurospheroids, which in turn interconnected via neuronal processes to form a centimeter-sized neurospheroid network (NSN). The NSN was transferable onto the cortical surface of the brain without damage of the neuronal network. After transfer onto the cortical tissue, the NSN showed neural activity for more than 8 days. Moreover, neurons of the transplanted NSN extended their axons into the host cortical tissue and established synaptic connections with host neurons. Our findings suggest that this method could lay the foundation for treating severe degenerative brain disease.
神经干细胞的神经移植疗法已被视为治疗神经退行性疾病的潜在疗法。事实上,这种疗法被认为对于替换特定解剖区域退化的神经元是有效的。然而,由于注入的神经干细胞随机整合到宿主神经网络中,因此需要另一种方法来建立大脑特定区域之间的神经通路或治疗多个大脑区域的广泛退化。一种有前途的方法可能是使用组织工程技术在体外预先构建神经网络的疗法。在这项研究中,我们设计了一种具有神经网络的三维(3D)组织,该组织可方便地进行操作,并可在体内移植到宿主脑组织上。聚二甲基硅氧烷微室阵列促进了多个神经球的形成,这些神经球通过神经元过程相互连接,形成了一个厘米大小的神经球网络(NSN)。NSN 可以转移到大脑皮质表面而不会损坏神经网络。转移到皮质组织后,NSN 的神经活动持续了 8 天以上。此外,移植的 NSN 的神经元将其轴突延伸到宿主皮质组织中,并与宿主神经元建立了突触连接。我们的研究结果表明,这种方法可能为治疗严重的退行性脑疾病奠定基础。